Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • 2026
  • April
  • Page 94
revolution’s-much-hyped-ras-inhibitor-hits-key-survival-goals-in-phase-3-pancreatic-cancer-trial
Posted inBiotechnology

Revolution’s much-hyped RAS inhibitor hits key survival goals in phase 3 pancreatic cancer trial

April 13, 2026
Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months…
Read More
adolescent-and-young-adult-cancer-survivors-face-twice-the-risk-of-developing-future-cancers
Posted inBiotechnology

Adolescent and Young Adult Cancer Survivors Face Twice the Risk of Developing Future Cancers

April 13, 2026
A groundbreaking population-based study conducted in Alberta, Canada, has uncovered compelling evidence that survivors of cancer diagnosed during adolescence and…
Read More
projected-cancer-trends-in-canada-for-2026:-what-the-future-holds
Posted inBiotechnology

Projected Cancer Trends in Canada for 2026: What the Future Holds

April 13, 2026
Cancer is poised to remain a formidable health challenge in Canada as the nation approaches 2026, according to the latest…
Read More
innovative-light-activated-mechanism-unveiled-for-regulating-plant-growth
Posted inBiotechnology

Innovative Light-Activated Mechanism Unveiled for Regulating Plant Growth

April 13, 2026
In a groundbreaking development that sheds new light on how plants regulate their growth, researchers at Osaka Metropolitan University have…
Read More
biontech,-synox-plot-paths-to-fda-as-trials-hit-goals-in-competitive-tumor-types
Posted inBiotechnology

BioNTech, SynOx plot paths to FDA as trials hit goals in competitive tumor types

April 13, 2026
The fight for two tumor types is poised to intensify, with BioNTech lining up a challenge to AstraZeneca, while SynOx Therapeutics…
Read More
regeneron-rides-into-radiopharma-via-$2.1b-biobucks-pact-with-australia’s-telix
Posted inBiotechnology

Regeneron rides into radiopharma via $2.1B biobucks pact with Australia’s Telix

April 13, 2026
With its latest obesity play appearing to pay off, Regeneron has turned its attention to radiopharmaceuticals. The New York-based biopharma…
Read More
harbinger-health-raises-$100m-for-new-suite-of-blood-based-cancer-detection-tests
Posted inMedical Technology

Harbinger Health raises $100M for new suite of blood-based cancer detection tests

April 13, 2026
Harbinger Health has grabbed $100 million in its latest funding round as the company reveals a new Resolve in its…
Read More
new-early-sjogren’s-diagnosis-via-lacrimal-doppler
Posted inBiotechnology

New Early Sjogren’s Diagnosis via Lacrimal Doppler

April 13, 2026
In a breakthrough that could revolutionize early diagnosis of Sjogren’s syndrome, researchers have unveiled a novel imaging technique that harnesses…
Read More
distinct-heart,-metabolic,-and-inflammatory-risk-profiles-found-in-men-and-women-with-obesity
Posted inBiotechnology

Distinct Heart, Metabolic, and Inflammatory Risk Profiles Found in Men and Women with Obesity

April 12, 2026
A groundbreaking study unveiled at the European Congress on Obesity 2026 in Istanbul, Turkey, has shed new light on the…
Read More
bio-based-sulfonated-cyclodextrin-catalyzes-5-hmf-synthesis
Posted inBiotechnology

Bio-Based Sulfonated Cyclodextrin Catalyzes 5-HMF Synthesis

April 12, 2026
In a groundbreaking advancement poised to reshape sustainable chemistry, researchers have unveiled a novel bio-based catalyst that can efficiently convert…
Read More

Posts pagination

Previous page 1 … 92 93 94 95 96 … 153 Next page

Privacy Policy    Terms

Scroll to Top